Skip to content
AwardedPOLGoods

Sukcesywne dostawy leku Elahere do nowego programu lekowego B.50. na potrzeby SPZOZ Opolskie Centrum Onkologii w Opolu

Published
Published 22 October 2025

Overview

Sukcesywne dostawy leku Elahere do nowego programu lekowego B.50. na potrzeby SPZOZ Opolskie Centrum Onkologii w Opolu, których rodzaje i ilości określa Załącznik nr 2 - Formularz asortymentowo-cenowy.

Key details

Country
POL
Status
Awarded
Category
Goods
Procedure
Direct
Published
22 October 2025
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
PLN 7,886,666
Award date
15 October 2025
Contract period
— → 10 October 2026
Winner
  • Abbvie Sp. z o.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    14 November 2025

  2. Contract Notice

    22 October 2025

Contracting authority

  • Samodzielny Publiczny Zakład Opieki Zdrowotnej Opolskie Centrum Onkologii im. prof. Tadeusza Koszarowskiego w Opolu

    Procuring entity

    Opole, POL

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Sukcesywne dostawy leku Elahere do nowego programu lekowego B.50. na potrzeby SPZOZ Opolskie Centrum Onkologii w Opolu — won by Abbvie Sp. z o.o. — Skim